- Record: found
- Abstract: not found
- Article: not found
Final results of a randomized phase 2 study showing the clinical benefit of quizartinib (AC220) in patients with FLT3-ITD positive relapsed or refractory acute myeloid leukemia
G.J. SCHILLER, M.S. Tallman, S.L. Goldberg, A.E. Perl, J.-P. Marie, G. MARTINELLI, R.A. LARSON, N. RUSSELL, D Trone, G Gammon, GJ Schiller, MS Tallman, SL Goldberg, AE Perl, JP Marie, RA Larson, MJ Levis, JE Cortes, G Martinelli, N Russell
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.